Justin D. Hoopes

875 total citations
11 papers, 625 citations indexed

About

Justin D. Hoopes is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Justin D. Hoopes has authored 11 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Justin D. Hoopes's work include Respiratory viral infections research (4 papers), Influenza Virus Research Studies (4 papers) and Viral Infections and Vectors (2 papers). Justin D. Hoopes is often cited by papers focused on Respiratory viral infections research (4 papers), Influenza Virus Research Studies (4 papers) and Viral Infections and Vectors (2 papers). Justin D. Hoopes collaborates with scholars based in United States, Netherlands and Morocco. Justin D. Hoopes's co-authors include Donald F. Smee, Gregory T. Went, Jack Nguyen, Lê Minh Hà, Mark N. Prichard, Robert W. Sidwell, Brian B. Gowen, Min‐Hui Wong, David M. Engelthaler and Amy K. Patick and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Justin D. Hoopes

11 papers receiving 614 citations

Peers

Justin D. Hoopes
Jamie Lovaglio United States
Mimi Guebre‐Xabier United States
Julia E. Biggins United States
Sanja Trifkovic United States
Virginia Takahashi United States
Lindsey Cass United Kingdom
Julien Sourimant United States
Jamie Lovaglio United States
Justin D. Hoopes
Citations per year, relative to Justin D. Hoopes Justin D. Hoopes (= 1×) peers Jamie Lovaglio

Countries citing papers authored by Justin D. Hoopes

Since Specialization
Citations

This map shows the geographic impact of Justin D. Hoopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin D. Hoopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin D. Hoopes more than expected).

Fields of papers citing papers by Justin D. Hoopes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin D. Hoopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin D. Hoopes. The network helps show where Justin D. Hoopes may publish in the future.

Co-authorship network of co-authors of Justin D. Hoopes

This figure shows the co-authorship network connecting the top 25 collaborators of Justin D. Hoopes. A scholar is included among the top collaborators of Justin D. Hoopes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin D. Hoopes. Justin D. Hoopes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Beigel, John H., Weerawat Manosuthi, Joy Beeler, et al.. (2019). Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial. Clinical Infectious Diseases. 70(11). 2317–2324. 10 indexed citations
2.
Hoopes, Justin D., Elizabeth M. Driebe, Erin Kelley, et al.. (2011). Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus. PLoS ONE. 6(12). e29778–e29778. 45 indexed citations
3.
Nguyen, Jack, Justin D. Hoopes, Lê Minh Hà, et al.. (2010). Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro. PLoS ONE. 5(2). e9332–e9332. 139 indexed citations
4.
Kumaki, Yohichi, Craig W. Day, Kevin W. Bailey, et al.. (2010). Induction of Interferon-γ-Inducible Protein 10 by SARS-CoV Infection, Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice. Antiviral chemistry & chemotherapy. 20(4). 169–177. 12 indexed citations
5.
Nguyen, Jack, Justin D. Hoopes, Donald F. Smee, et al.. (2009). Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro. Antimicrobial Agents and Chemotherapy. 53(10). 4115–4126. 92 indexed citations
6.
Smee, Donald F., Brian B. Gowen, Miles K. Wandersee, et al.. (2008). Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. International Journal of Antimicrobial Agents. 31(4). 352–359. 25 indexed citations
7.
Julander, Justin G., Ramona T. Skirpstunas, Venkatraman Siddharthan, et al.. (2008). C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Research. 78(3). 230–241. 45 indexed citations
8.
Pickering, Jerry W., et al.. (2007). A 22-plex Chemiluminescent Microarray for Pneumococcal Antibodies. American Journal of Clinical Pathology. 128(1). 23–31. 20 indexed citations
9.
Liew, Michael, James E. Thompson, Justin D. Hoopes, et al.. (2007). Validating a Custom Multiplex ELISA Against Individual Commercial Immunoassays Using Clinical Samples. BioTechniques. 42(3). 327–333. 50 indexed citations
10.
Barnard, Dale L., Craig W. Day, Kevin W. Bailey, et al.. (2006). Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. Antiviral Research. 71(1). 53–63. 85 indexed citations
11.
Gowen, Brian B., Justin D. Hoopes, Min‐Hui Wong, et al.. (2006). TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection. The Journal of Immunology. 177(9). 6301–6307. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026